MoonLake Immunotherapeutics (MLTX)

• Market cap: $1.12B
• 1 day: 1.02%
• 5 days: 1.74%
• 1 month: -7.78%
• 3 months: 25.56%
• 6 months: -71.66%
• Year to date: 31.97%
• 1 year: -63.83%
• 5 years: 40.05%
• 10 years: 50.33%
• Sector: Healthcare
• Industry: Biotechnology

About: MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Employees: 100